Sign up to save your podcasts
Or
Share The $10 Billion VC: Why Most Biotech Startups Fail & How To Scale Them | Ready Set Exec
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The $10 Billion VC: Why Most Biotech Startups Fail & How To Scale Them | Ready Set Exec
In this episode of Ready Set Exec, Host John Pezoulas sits down with William Grenawitzke (Bellows Capital Partners, Erez Capital) to break down the brutal reality of scaling life science enterprises. Backed by two decades of experience and $10B+ in global M&A, William reveals how AI is disrupting MedTech, why biotech startups fail to raise capital, and the hidden mechanics of corporate development. For founders seeking funding and executives navigating acquisitions, this VC masterclass is mandatory listening.
Key Takeaways:
- The reality of managing $10 Billion in global M&A transactions.
- Why most biopharma and MedTech startups fail to secure capital and how to survive the Valley of Death.
- How Artificial Intelligence is aggressively disrupting healthcare and Proptech.
- The operational mechanics of scaling mid-market corporate development.
- William's leadership journey from Yale academia to Wall Street and his philanthropic work with underserved youth.
About Ready Set Exec: Founded by Managing Partners Patrick Shea and John Pezoulas, Ready Set Exec is a premier North American executive leadership recruitment firm specializing in Sales, Marketing, Human Resources, and Operations. We replace hiring chaos with a repeatable process, with an average 39-day time-to-hire and a 100% placement success rate.
Chapters:
00:00:00 - Introduction: Bridging Deep Science, AI, and High Finance 00:03:15 - The Reality of Managing $10 Billion in Corporate M&A Transactions 00:08:42 - Why Most Biopharma and MedTech Startups Fail to Raise Capital 00:14:20 - Surviving the "Valley of Death" in Life Sciences Innovation 00:19:05 - How Erez Capital is Using AI to Disrupt Healthcare and Proptech 00:24:30 - The Transition from Yale Academia to Wall Street Investment Banking 00:31:15 - Bellows Capital Partners: Scaling Mid-Market Corporate Development 00:37:45 - The Importance of Rigorous Due Diligence in Medical Technology Investments 00:44:10 - Leadership Lessons from Two Decades in the Global Boardroom 00:49:50 - Personal Resilience, Adoption, and Giving Back with the HATW Board 00:55:20 - The Future of Venture Capital, AI, and Executive Leadership in 2026
Connect with Ready Set Exec:
- John Pezoulas LinkedIn: https://www.linkedin.com/in/johnpezoulas/
- Patrick Shea LinkedIn: https://linkedin.com/in/patrick-jm-shea/
Connect with William Grenawitzke:
- LinkedIn: https://www.linkedin.com/in/william-grenawitzke/
View all episodes
By Ready Set Exec Inc.In this episode of Ready Set Exec, Host John Pezoulas sits down with William Grenawitzke (Bellows Capital Partners, Erez Capital) to break down the brutal reality of scaling life science enterprises. Backed by two decades of experience and $10B+ in global M&A, William reveals how AI is disrupting MedTech, why biotech startups fail to raise capital, and the hidden mechanics of corporate development. For founders seeking funding and executives navigating acquisitions, this VC masterclass is mandatory listening.
Key Takeaways:
- The reality of managing $10 Billion in global M&A transactions.
- Why most biopharma and MedTech startups fail to secure capital and how to survive the Valley of Death.
- How Artificial Intelligence is aggressively disrupting healthcare and Proptech.
- The operational mechanics of scaling mid-market corporate development.
- William's leadership journey from Yale academia to Wall Street and his philanthropic work with underserved youth.
About Ready Set Exec: Founded by Managing Partners Patrick Shea and John Pezoulas, Ready Set Exec is a premier North American executive leadership recruitment firm specializing in Sales, Marketing, Human Resources, and Operations. We replace hiring chaos with a repeatable process, with an average 39-day time-to-hire and a 100% placement success rate.
Chapters:
00:00:00 - Introduction: Bridging Deep Science, AI, and High Finance 00:03:15 - The Reality of Managing $10 Billion in Corporate M&A Transactions 00:08:42 - Why Most Biopharma and MedTech Startups Fail to Raise Capital 00:14:20 - Surviving the "Valley of Death" in Life Sciences Innovation 00:19:05 - How Erez Capital is Using AI to Disrupt Healthcare and Proptech 00:24:30 - The Transition from Yale Academia to Wall Street Investment Banking 00:31:15 - Bellows Capital Partners: Scaling Mid-Market Corporate Development 00:37:45 - The Importance of Rigorous Due Diligence in Medical Technology Investments 00:44:10 - Leadership Lessons from Two Decades in the Global Boardroom 00:49:50 - Personal Resilience, Adoption, and Giving Back with the HATW Board 00:55:20 - The Future of Venture Capital, AI, and Executive Leadership in 2026
Connect with Ready Set Exec:
- John Pezoulas LinkedIn: https://www.linkedin.com/in/johnpezoulas/
- Patrick Shea LinkedIn: https://linkedin.com/in/patrick-jm-shea/
Connect with William Grenawitzke:
- LinkedIn: https://www.linkedin.com/in/william-grenawitzke/